News

Lilly’s Zepbound Faces a Potential Weight-Loss Rival. It’s Made by a Chinese Biotech.
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
How Hims Became the King of Knockoff Weight-Loss Drugs
Big Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no ...
Kailera touts late-stage win for weight-loss drug in China
U.S.-based Kailera Therapeutics and Chinese firm Jiangsu Hengrui Pharmaceuticals' experimental weight-loss drug has helped overweight patients lose up to 17.7% of body weight in a late-stage study in ...
Hengrui, Kailera say dual-acting obesity shot succeeds in China study
The results position Hengrui to seek approval of the Zepbound-like drug in China and Kailera, a well-funded biotech startup, ...